CCCatarina Costa

Catarina Costa

*This is an algorithmically generated author record based on publicly available information.

Research Subjects

Research Interests


Catarina Costa has a total of 25 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Primary Small Cell Carcinoma of the Thyroid With Absent Calcitonin Expression: A Diagnostic Challenge

    by João Carlos Almeida, Patrícia Andrea‐Ferreira, Catarina Costa, Pedro Amoroso Canão, Elisabete Rodrigues, Manuel Sobrinho‐Simões, José Manuel Cameselle‐Teijeiro

    Primary small cell carcinoma of the thyroid is an exceedingly rare and aggressive neuroendocrine malignancy. Diagnosis may be particularly challenging in tumors lacking calcitonin expression, in which distinction from medullary thyroid carcinoma and metastatic neuroendocrine carcinomas is required. A 50‐year‐old woman presented with progressive hoarseness and a rapidly enlarging cervical mass. Imaging revealed a highly infiltrative thyroid tumor with multiple cervical lymphadenopathies and no evidence of a primary tumor elsewhere. Serum calcitonin levels were within normal limits. Fine‐needle aspiration biopsy of the thyroid lesion and a cervical lymph node demonstrated cytologic features consistent with small cell carcinoma. Following a good response to neoadjuvant chemotherapy, total thyroidectomy with central, bilateral mediastinal lymphadenectomy was performed. Histologic examination demonstrated a highly infiltrative neoplasm composed of small cells arranged in solid and nested patterns with marked mitotic activity, tumor necrosis, and vascular and perineural invasion. Tumor cells expressed neuroendocrine markers with focal positivity for TTF‐1/NKX2‐1 and CEA, while calcitonin, thyroglobulin, PAX8, and CGRP were negative. Primary thyroid small cell carcinoma is exceptionally rare and its histogenesis remains uncertain. Diagnosis requires careful clinicopathologic correlation and exclusion of metastatic disease and calcitonin‐negative variants of medullary thyroid carcinoma.

  • Open Access

    Pitiríase rubra pilar após vacinação contra COVID‐19: tratamento bem‐sucedido com ustequinumabe

    by Bárbara Vieira Granja, Patrícia Amoedo, Nuno Preto Gomes, Catarina Costa, Filomena Azevedo, Sofia Magina

  • Open Access

    Pityriasis rubra pilaris after COVID-19 vaccination: successful treatment with ustekinumab

    by Bárbara Vieira Granja, Patrícia Amoedo, Nuno Preto Gomes, Catarina Costa, Filomena Azevedo, Sofia Magina


  • Open Access

    Acute total occlusion of the unprotected left main coronary artery – patient characteristics and outcomes

    by J Calvao, M Braga, M Brandao, A Campinas, A Alexandre, A F Amador, C Costa, M M Carvalho, R A Pinto, T Proenca, et al.

    Background: Acute total occlusion of the unprotected left main coronary artery (ATOLMCA) is a dramatic entity with very high mortality. Owing to its infrequency, there is limited and inconsistent data regarding this population. Purpose: To describe the clinical presentation, short- and long-term outcomes of patients with ATOLMCA. Methods: This retrospective multicentric cohort study included all patients presenting with acute (<12h) myocardial infarction (MI) due to ATOLMCA (Thrombolysis In Myocardial Infarction - TIMI=0) between January 2008 and December 2020 in three tertiary hospitals. Results: In the period of the study, 11,036 emergent coronary angiographies were performed in the participating centers, 59 of which were ATOLMCA (0.5%). Mean age of patients at the time of the event was 61.2 (±12.2) years. Seventy-three percent were male. At presentation, 72.9% of patients were in cardiogenic shock, and aborted cardiac arrest occurred in 27.1%. Right dominance was present in all patients except one, who had a balanced dominance. Primary percutaneous coronary intervention (PCI) was performed in 89.8% of the patients, with angiographic success being achieved in 55.6% of the procedures. Overall, the in-hospital mortality rate was 57.6%. Mortality was significantly higher in patients without angiographic criteria for PCI success (87.5 vs 36.7%, p<0.001). Among survivors, 91.7% were still alive at 1-year and 66.7% at 5 years of follow-up. Conclusion: Patients with ATOLMCA have a dismal prognosis. Most patients present with cardiogenic shock, and a significant number develop cardiac arrest during the acute phase. Despite medical care, in-hospital mortality is high. Patients with left dominance may not even reach the hospital. Among survivors, long term outcomes are reasonable. Further studies are needed in order to improve the management and outcomes of patients with ATOLMCA. Funding Acknowledgement: Type of funding sources: None.